Gelteq (GELS) Non-Current Assets (2023 - 2025)
Gelteq's (GELS) quarterly Non-Current Assets came in at $12.9 million in Q4 2025, down 2.51% year-on-year from $13.2 million in Q4 2024, and little changed quarter-over-quarter from $12.9 million in Q2 2025.
Gelteq (GELS) Non-Current Assets (2023 - 2025) Analysis & Trends
Gelteq's Non-Current Assets history runs 3 years deep, the most recent figure standing at $12.9 million for Q4 2025.
- On a quarterly basis, Non-Current Assets fell 2.51% year-over-year to $12.9 million in Q4 2025; TTM through Dec 2025 was $12.9 million, a 2.51% decrease from a year earlier, with the FY2025 full-year figure at $12.9 million, down 4.28% from the prior year.
- Non-Current Assets steadied at $12.9 million in Q4 2025 per GELS's latest filing, from $12.9 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $14.4 million in Q2 2023 and bottomed at $12.9 million in Q4 2025.
- The 3-year median for Non-Current Assets is $13.2 million (2024), against an average of $13.4 million.
- Across the five-year window, Non-Current Assets fell 6.21% in 2024 and fell 2.51% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $14.4 million in 2023, then retreated by 8.19% to $13.2 million in 2024, then slipped by 2.51% to $12.9 million in 2025.
- Per Business Quant, the three latest GELS Non-Current Assets figures stand at $12.9 million (Q4 2025), $12.9 million (Q2 2025), and $13.2 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | Gelteq | 740.00 | -47,821.64 | - | 12.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.86 Mn |
| Jun 30, 2025 | 12.90 Mn |
| Dec 31, 2024 | 13.19 Mn |
| Jun 30, 2024 | 13.48 Mn |
| Jun 30, 2023 | 14.37 Mn |